FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

  
gfedcb

If this is a report of a second or subsequent transplant, check here and continue with question 29.

 
 
1  What was the date abnormal platelet counts were first observed? __ __ __ __ - __ __- __ __  

 
 
2  What was the date of diagnosis of Congenital Amegakaryocytic Thrombocytopenia? __ __ __ __ - __ __- __ __  

 
 

3  WBC:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
4  .    

 
Unit:

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

5  Hemoglobin (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
6  .    

 
Unit:

 nmlkji
g/dL  

 nmlkji
g/L  

 nmlkji
mmol/L  

 
 

7  Platelets (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
8  .    

 
Unit:

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

9  Neutrophils:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
10  .    % 

  Key Fields 

Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data Questions: 1 - 2

  Hemotologic Findings at Diagnosis Questions: 3 - 17

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 7



 
 

11  Was the bone marrow examined at diagnosis?

    
 nmlkji

yes  
 nmlkji

no  

 
 
12  Specify the date the bone marrow was examined: __ __ __ __ - __ __- __ __  

 
 

13  What was the cellularity of the bone marrow at diagnosis?

    
 nmlkji

Decreased  
 nmlkji

Normal  
 nmlkji

Increased  

 
 

14  What was the megakaryocyte level in the bone marrow at diagnosis?

    
 nmlkji

Decreased  
 nmlkji

Absent  

 
 

15  Were radiographs of radii performed at diagnosis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

16  Were the radii present?

    
 nmlkji

yes  
 nmlkji

no  

 
 

17  Did the radii appear normally developed?

    
 nmlkji

yes  
 nmlkji

no  

 
 

18  Did the recipient's mother develop thrombocytopenia while pregnant with the recipient?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

19  Was the mother tested for the presence of GPIIIA platelet antigen?

    
 nmlkji

yes  
 nmlkji

no  

 
 

20  Specify results:

    
 nmlkji

GPIIIA platelet antigen present  

 nmlkji
GPIIIA platelet antigen absent  

 
 

21  Have any of the recipient's family members been diagnosed with thrombocytopenia?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify relationship to recipient: 
 

22  Aunt / uncle

    
 nmlkji

yes  
 nmlkji

no  

 
 

23  Cousin

    
 nmlkji

yes  
 nmlkji

no  

 
 

24  Parent

    
 nmlkji

yes  
 nmlkji

no  

 
 

25  Sibling

    
 nmlkji

yes  
 nmlkji

no  

 
 

26  Other blood relative

    
 nmlkji

yes  
 nmlkji

no  

 
 
27  Specify relationship:    

 
 

28  Do the recipient's parents share a close degree of consanguinuity (descent from common ancestors / interfamilial marriage)?

    
 nmlkji

yes  
 nmlkji

no  

  Family History of Thrombocytopenia Questions: 18 - 28

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 7



 
 

29  Did the recipient receive any treatment(s) for CAT at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify treatment(s) given: 
 

30  Androgens

    
 nmlkji

yes  
 nmlkji

no  

 
 

31  Growth factors

    
 nmlkji

yes  
 nmlkji

no  

 

Specify growth factors given: 
 

32  Erythropoietin (all formulations)

    
 nmlkji

yes  
 nmlkji

no  

 
 

33  G-CSF (all formulations)

    
 nmlkji

yes  
 nmlkji

no  

 
 

34  GM-CSF

    
 nmlkji

yes  
 nmlkji

no  

 
 

35  Neumega (oprelvekin, IL-11)

    
 nmlkji

yes  
 nmlkji

no  

 
 

36  Thrombopoietin

    
 nmlkji

yes  
 nmlkji

no  

 
 

37  Other

    
 nmlkji

yes  
 nmlkji

no  

 
 
38  Specify:    

 
 

39  Steroids

    
 nmlkji

yes  
 nmlkji

no  

 
 

40  Transfusions

    
 nmlkji

yes  
 nmlkji

no  

 
 
41  Specify the number of red blood cell transfusions given (best estimate):    units 

 
 

42  Were single donor platelet transfusions given?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
43  Specify the total number of aphereses:    

 
 

44  Were random donor platelet transfusions given?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
45  Specify the total number of donors:    

 
 

46  Other treatment

    
 nmlkji

yes  
 nmlkji

no  

 
 
47  Specify:    

 
 

48  Did the recipient undergo a splenectomy at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 
 

49  Was there any evidence of allosensitization at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

  Disease Treatment Prior to the Preparative Regimen Questions: 29 - 119

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 7



 
 

50  Specify the method of allosensitization identification:

    
 nmlkji

inadequate rise in platelet count to transfusion  

 nmlkji
anti-platelet antibodies developed  

 nmlkji
antibodies to HLA antigens  

 
 

51  Did the recipient develop myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

52  Is a completed MDS or AML insert attached to this report?

    
 nmlkji

yes  
 nmlkji

no  

 
 

53  Was a bone marrow karyotype examination performed at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

54  Were any karyotype abnormalities identified?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify the abnormalities identified when tested at diagnosis: 
 

55  -5

    
 nmlkji

yes  
 nmlkji

no  

 
 

56  -7

    
 nmlkji

yes  
 nmlkji

no  

 
 

57  -17

    
 nmlkji

yes  
 nmlkji

no  

 
 

58  -18

    
 nmlkji

yes  
 nmlkji

no  

 
 

59  -20

    
 nmlkji

yes  
 nmlkji

no  

 
 

60  -X

    
 nmlkji

yes  
 nmlkji

no  

 
 

61  -Y

    
 nmlkji

yes  
 nmlkji

no  

 
 

62  +4

    
 nmlkji

yes  
 nmlkji

no  

 
 

63  +8

    
 nmlkji

yes  
 nmlkji

no  

 
 

64  +11

    
 nmlkji

yes  
 nmlkji

no  

 
 

65  +13

    
 nmlkji

yes  
 nmlkji

no  

 
 

66  +14

    
 nmlkji

yes  
 nmlkji

no  

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 7



 
 

67  +21

    
 nmlkji

yes  
 nmlkji

no  

 
 

68  +22

    
 nmlkji

yes  
 nmlkji

no  

 
 

69  del(5q) / 5q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

70  del(7q) / 7q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

71  del(9q) / 9q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

72  del(11q) / 11q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

73  del(17q) / 17q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

74  del(20q) / 20q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

75  inv(3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

76  inv(16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

77  t(3;3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

78  t(6;9)

    
 nmlkji

yes  
 nmlkji

no  

 
 

79  t(8;21)

    
 nmlkji

yes  
 nmlkji

no  

 
 

80  t(15;17) and variants

    
 nmlkji

yes  
 nmlkji

no  

 
 

81  t(16;16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

82  (11q23) balanced abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 

83  12p any abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 

84  complex (≥ 3 distinct abnormalities)

    
 nmlkji

yes  
 nmlkji

no  

 
 

85  other abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 
86  Specify:    

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 5 / 7



 

Specify the abnormalities identified when tested prior to preparative regimen 
 

87  -5

    
 nmlkji

yes  
 nmlkji

no  

 
 

88  -7

    
 nmlkji

yes  
 nmlkji

no  

 
 

89  -17

    
 nmlkji

yes  
 nmlkji

no  

 
 

90  -18

    
 nmlkji

yes  
 nmlkji

no  

 
 

91  -20

    
 nmlkji

yes  
 nmlkji

no  

 
 

92  -X

    
 nmlkji

yes  
 nmlkji

no  

 
 

93  -Y

    
 nmlkji

yes  
 nmlkji

no  

 
 

94  +4

    
 nmlkji

yes  
 nmlkji

no  

 
 

95  +8

    
 nmlkji

yes  
 nmlkji

no  

 
 

96  +11

    
 nmlkji

yes  
 nmlkji

no  

 
 

97  +13

    
 nmlkji

yes  
 nmlkji

no  

 
 

98  +14

    
 nmlkji

yes  
 nmlkji

no  

 
 

99  +21

    
 nmlkji

yes  
 nmlkji

no  

 
 

100  +22

    
 nmlkji

yes  
 nmlkji

no  

 
 

101  del(5q) / 5q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

102  del(7q) / 7q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

103  del(9q) / 9q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

104  del(11q) / 11q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

105  del(17q) / 17q-

    
 nmlkji

yes  
 nmlkji

no  

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 6 / 7



 
 

106  del(20q) / 20q-

    
 nmlkji

yes  
 nmlkji

no  

 
 

107  inv(3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

108  inv(16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

109  t(3;3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

110  t(6;9)

    
 nmlkji

yes  
 nmlkji

no  

 
 

111  t(8;21)

    
 nmlkji

yes  
 nmlkji

no  

 
 

112  t(15;17) and variants

    
 nmlkji

yes  
 nmlkji

no  

 
 

113  t(16;16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

114  (11q23) balanced abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 

115  12p any abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 

116  complex (≥ 3 distinct abnormalities)

    
 nmlkji

yes  
 nmlkji

no  

 
 

117  other abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 
118  Specify:    

 
 

119  Is a copy of the cytogenetic report attached?

    
 nmlkji

yes  
 nmlkji

no  

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

Form 2035 R2.0: Congenital Amegakaryocytic Thrombocytopenia Pre-HSCT Data  
Center:  CRID: 

               CIBMTR Form 2035 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 7 / 7